Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues | Reuters

By Zeba Siddiqui | MUMBAI MUMBAI Sun Pharmaceutical Industries, India's largest drugmaker, reported its first fall in quarterly profits in a year on Tuesday, as pricing issues and supply constraints affected sales in the United States, its largest market.Sun's U.S. business faces increasing uncertainty as it struggles to fix quality control problems found by regulators at its key drug factories, and is the subject of a U.S. Department of Justice investigation into increases in drug prices.On Tuesday the world's fifth-largest generic drugs maker sought to allay those concerns by saying its focus was on high-margin 'specialty' products.'The idea for us is to improve our supply and regain market share ..

Reuters February 14, 2017 22:18:25 IST
Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues
| Reuters

Sun Pharmas profits drop as US sales hit by pricing supply issues
 Reuters

By Zeba Siddiqui
| MUMBAI

MUMBAI Sun Pharmaceutical Industries, India's largest drugmaker, reported its first fall in quarterly profits in a year on Tuesday, as pricing issues and supply constraints affected sales in the United States, its largest market.Sun's U.S. business faces increasing uncertainty as it struggles to fix quality control problems found by regulators at its key drug factories, and is the subject of a U.S. Department of Justice investigation into increases in drug prices.On Tuesday the world's fifth-largest generic drugs maker sought to allay those concerns by saying its focus was on high-margin 'specialty' products."The idea for us is to improve our supply and regain market share ... our plan is to create a very successful specialty business," billionaire founder and Managing Director Dilip Shanghvi told analysts on a conference call.U.S. supplies have been hit over the past year after the Food and Drug Administration (FDA) found violations in manufacturing practices at Sun's Halol factory in western India. Sun has spent months trying to resolve those concerns but the FDA outlined further problems with the plant in an inspection report in December.

Shanghvi said on Tuesday the company hoped to be able to fix the problems at Halol "over the next few quarters."Some other factories that the drugmaker took over with the acquisition of rival Ranbaxy in 2014 are still barred from supplying. Sun said it was cooperating with a U.S. Department of Justice investigation, under which several drugmakers were subpoenaed last year. "We have followed the law in the U.S. and all our people have followed appropriate behaviour," Shanghvi said.

Chief Financial Officer Uday Baldota said competitive pressures also continued to affect the U.S. business. Sun earlier reported a 4 percent rise in U.S. sales in the final three months of 2016, but its total net profit fell to 14.72 billion rupees ($220 million) from 15.45 billion rupees in the same period of 2015. Analysts on average had expected a profit of 17.83 billion rupees, according to Thomson Reuters I/B/E/S Estimates.

The company's majority-owned U.S. subsidiary Taro Pharmaceutical Industries Ltd last week reported a 15 percent drop in quarterly sales for the same period, mainly due to price erosion in the United States. Changes to healthcare policy under President Donald Trump also look likely to affect companies like Sun, which generates 45 percent of its revenue from the U.S. market. Trump last month proposed imposing a 'border tax' on companies exporting to the United States.($1 = 66.9500 rupees) (Reporting by Zeba Siddiqui in Mumbai; Editing by Vyas Mohan, Greg Mahlich)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.